Wednesday, January 12, 2022 5:51:46 PM
01/11/2022 02:36 PM
[Medigen and Ino were selected by the WHO’s SVT.]
Taipei, Jan. 11 (CNA) Thailand has become the fifth country in the world to recognize the COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics, according to a list released by Thailand's government on Monday.
The Medigen vaccine was added to a list of eight previously recognized vaccines that will enable travelers to visit Thailand under its new tourism sandbox plan, according to the Thailand foreign ministry's Department of Consular Affairs.
The previously accepted COVID-19 vaccine brands were Sinovac, AstraZeneca, Pfizer-BioNTech, Moderna, Sinopharm, Johnson & Johnson, Sputnik V, and Covaxin (a vaccine developed in India).
Under the tourism sandbox plan that began Tuesday, travelers fully vaccinated with one of the nine vaccine brands can stay in one of several designated locales, including Phuket, Phang-gna, Krabi, Koh Samui, Koh Tao, and Koh Pha-ngan, for seven days after arriving in the country.
Once the seven-day period has ended, they can then travel to other parts of Thailand.
The sandbox plan will replace Thailand's TEST & GO program, which was launched in November 2021 and suspended a month later. That program enabled travelers from low-risk countries including Taiwan, who tested negative for COVID, to avoid quarantine.
Thailand is now the fifth country around the globe that allows travelers who have received the Medigen vaccine to either enter the country or face a shorter mandatory quarantine period, after New Zealand, Palau, Indonesia, and Belize.
Medigen Vaccine Biologics said Tuesday it appreciated the Thailand government's recognition and that its main focus now was to gain EUA (emergency use authorization) approval from the World Health Organization (WHO).
Medigen is the only domestically developed COVID-19 vaccine that has received an EUA from Taiwan's Food and Drug Administration, and its rollout in Taiwan began on Aug. 23.
So far, no other country has given Medigen full or emergency use authorization.
Medigen's COVID-19 vaccine is currently undergoing a clinical trial in Paraguay and has also been chosen to take part in the Solidarity Trial Vaccines platform, an international clinical trial platform co-launched by the WHO.
Its vaccine has also passed the first hurdle in getting provisional approval for use in Australia after it was granted "provisional determination" status by the country's Therapeutic Goods Administration (TGA) in November 2021.
https://focustaiwan.tw/society/202201110009
Recent INO News
- INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants • PR Newswire (US) • 04/15/2024 10:39:00 PM
- INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine • PR Newswire (US) • 03/26/2024 10:28:00 PM
- INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights • PR Newswire (US) • 03/06/2024 09:05:00 PM
- Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting • PR Newswire (US) • 03/06/2024 12:00:00 PM
- U.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices Climb • IH Market News • 03/06/2024 11:02:03 AM
- INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024 • PR Newswire (US) • 02/21/2024 01:00:00 PM
- INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • PR Newswire (US) • 02/07/2024 04:46:00 PM
- INOVIO Reports Inducement Grant Under Inducement Plan • PR Newswire (US) • 02/02/2024 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/01/2024 05:15:24 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:01:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:02:31 PM
- INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split • PR Newswire (US) • 01/23/2024 01:00:00 PM
- INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader • PR Newswire (US) • 01/22/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 10:27:59 PM
- INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi) • PR Newswire (US) • 01/04/2024 01:00:00 PM
- INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program • PR Newswire (US) • 01/03/2024 01:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2023 09:05:57 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/17/2023 09:00:28 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/09/2023 09:35:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:15:59 PM
- INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights • PR Newswire (US) • 11/09/2023 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:00:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:01:55 PM
- INOVIO Reports Inducement Grants Under Inducement Plan • PR Newswire (US) • 11/01/2023 12:00:00 PM
- INOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023 • PR Newswire (US) • 10/26/2023 12:00:00 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM